Ferric Carboxymaltose Equal to Element Iron Injection

Anemmaric Injection is an intravenous iron formulation containing Ferric Carboxymaltose, used for the treatment of iron deficiency anemia (IDA) in adult and adolescent patients who are intolerant to oral iron, have had an unsatisfactory response to oral iron therapy, or require rapid iron replenishment.

Mechanism of Action:
Ferric Carboxymaltose is a stable iron-carbohydrate complex that allows controlled release of iron. After administration, the complex is taken up by macrophages, and iron is gradually released for incorporation into hemoglobin and essential enzymes.

Indications:

• Iron deficiency anemia due to chronic blood loss, heavy menstruation, post-partum anemia, or inflammatory bowel disease
• Iron deficiency associated with chronic kidney disease
• Situations requiring rapid correction of iron stores

Dosage & Administration:

• Administered intravenously either as a slow IV injection or infusion
• Dosage is based on patient’s weight and hemoglobin level
• Typically requires 1–2 doses for full correction of deficiency

Side Effects:

• Headache,
• Nausea,
• Dizziness,
• Flushing,
• injection site pain or discoloration

Precautions:

Not recommended in patients with iron overload, non-iron deficiency anemia, or known hypersensitivity to intravenous iron preparations. Use with caution in liver disease, infection, or during pregnancy and lactation under medical supervision.

Storage:

Store below 28°C. Do not freeze. Keep away from children. For single use only.

Packaging:

Available in 10 mL and 20 mL single-dose glass vials.
Each mL contains Ferric Carboxymaltose equivalent to 50 mg elemental iron.

Prescription Status:

Rx – To be sold by retail on the prescription of a registered medical practitioner only.